Treatment with sodium‐glucose cotransporter 2 inhibitors and risk of lower‐limb amputations
Diabetes, Obesity and Metabolism · 2024
DOI: 10.1111/dom.15775 ↗Kurz gefasst
Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Ivan Tkáč und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine 4, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovakia. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Amputation, Surgical, Diabetes Mellitus, Type 2, Diabetic Foot. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.15775. Our data will be available on request.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine 4, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovakia.
- Louis Pasteur University Hospital, Košice, Slovakia.
ORCID-Profile: Ivan Tkáč
Zitieren
APA
Tkáč, I., Kozárová, M., Stančáková Yaluri, A., & Javorský, M. (2024). Treatment with sodium‐glucose cotransporter 2 inhibitors and risk of lower‐limb amputations. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15775
Vancouver
Tkáč I, Kozárová M, Stančáková Yaluri A, Javorský M. Treatment with sodium‐glucose cotransporter 2 inhibitors and risk of lower‐limb amputations. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15775
BibTeX
@article{Tk2024,
author = {Tkáč, Ivan and Kozárová, Miriam and Stančáková Yaluri, Alena and Javorský, Martin},
title = {Treatment with sodium‐glucose cotransporter 2 inhibitors and risk of lower‐limb amputations},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
doi = {10.1111/dom.15775}
}
EUVIMED